Yinxing Zhu

814 total citations
31 papers, 543 citations indexed

About

Yinxing Zhu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yinxing Zhu has authored 31 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Yinxing Zhu's work include Ferroptosis and cancer prognosis (4 papers), Nanoparticle-Based Drug Delivery (4 papers) and HER2/EGFR in Cancer Research (4 papers). Yinxing Zhu is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Nanoparticle-Based Drug Delivery (4 papers) and HER2/EGFR in Cancer Research (4 papers). Yinxing Zhu collaborates with scholars based in China. Yinxing Zhu's co-authors include Cuiju Tang, Wenwen Zhang, Xuedan Zhu, Xiaoxiang Guan, Xiaowei Wei, Mei Lin, Ting Guo, Li Z, Fujin Wang and Junfeng Shi and has published in prestigious journals such as Frontiers in Immunology, Carcinogenesis and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Yinxing Zhu

29 papers receiving 532 citations

Peers

Yinxing Zhu

ONCOL

PRM

IMMUN

Alessandra I. Riggio United Kingdom

Xinghua Han China

He Dou China

Teresa Puértolas Spain

Gemma Shay United States

Zhenzhen Xu China

Vasilios Liapis Australia

Tomás G. Lyons United States

Daniel J. Smit Germany

Pietro Parcesepe Italy

Alessandra I. Riggio United Kingdom

Yinxing Zhu

232 ×1.0

ONCOL

228 ×1.1

84 ×0.5

PRM

148 ×1.2

63 ×0.7

IMMUN

Citations per year, relative to Yinxing Zhu Yinxing Zhu (= 1×) peers Alessandra I. Riggio

Countries citing papers authored by Yinxing Zhu

Since Specialization

Citations

This map shows the geographic impact of Yinxing Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinxing Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinxing Zhu more than expected).

Fields of papers citing papers by Yinxing Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinxing Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinxing Zhu. The network helps show where Yinxing Zhu may publish in the future.

Co-authorship network of co-authors of Yinxing Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yinxing Zhu. A scholar is included among the top collaborators of Yinxing Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinxing Zhu. Yinxing Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Qianqian, Chunming Tang, Jie Li, et al.. (2025). Biomimetic nanocrystals co-deliver paclitaxel and small-molecule LF3 for ferroptosis-combined chemotherapy for gastric cancer. Colloids and Surfaces B Biointerfaces. 251. 114586–114586. 1 indexed citations

Zhu, Yinxing, et al.. (2024). Trop2-targeted therapy in breast cancer. Biomarker Research. 12(1). 82–82. 16 indexed citations

Qian, Lichao, et al.. (2024). In silico identification and verification of Tanshinone IIA-related prognostic genes in hepatocellular carcinoma. Frontiers in Immunology. 15. 1482914–1482914. 3 indexed citations

Ding, Yan, et al.. (2024). Causal Pathways Between Breast Cancer and Cardiovascular Disease Through Mediator Factors: A Two-Step Mendelian Randomization Analysis. International Journal of Women s Health. Volume 16. 1889–1902.

Qian, Lichao, Zhao Gao, Lihua Wu, et al.. (2024). Drug pair of Cornus officinalis and Radix achyranthis bidentatae improves renal injury of hypertension by regulating metabolic reprogramming mediated by eNOS. Heliyon. 10(12). e33369–e33369.

Jiang, Min, et al.. (2024). A cause-effect relationship between uterine diseases and breast cancer: A bidirectional Mendelian randomization study. Heliyon. 10(18). e38130–e38130. 1 indexed citations

Bian, Xuefeng, et al.. (2024). The therapeutic effect and MR molecular imaging of FA-PEG-FePt/DDP nanoliposomes in AMF on ovarian cancer. International Journal of Nanomedicine. Volume 19. 5227–5243. 1 indexed citations

Zhu, Yinxing, Junfeng Shi, Xiaowei Wei, et al.. (2024). Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast Cancer. Clinical Breast Cancer. 24(6). e464–e473.e3. 1 indexed citations

Ma, Jun, et al.. (2024). Photo-Thermally Controllable Tumor Metabolic Modulation to Assist T Cell Activation for Boosting Immunotherapy. International Journal of Nanomedicine. Volume 19. 11181–11194. 2 indexed citations

10.

Peng, Hailin, et al.. (2024). Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments. Biomolecules. 14(9). 1161–1161. 12 indexed citations

11.

Zhu, Yinxing, et al.. (2024). Elucidating the role of liver enzymes as markers and regulators in ovarian cancer: a synergistic approach using Mendelian randomization, single-cell analysis, and clinical evidence. Human Genomics. 18(1). 71–71. 2 indexed citations

12.

Bian, Xuefeng, et al.. (2024). ADT‐UNet: An Innovative Algorithm for Glioma Segmentation in MR Images. International Journal of Imaging Systems and Technology. 34(5). 1 indexed citations

13.

Zhu, Yinxing, Junfeng Shi, Xiaowei Wei, et al.. (2023). Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer. Technology in Cancer Research & Treatment. 22. 2223926883–2223926883. 1 indexed citations

14.

Zhu, Yinxing, et al.. (2023). Thioredoxin reductase as a novel biomarker for the diagnosis and efficacy prediction of gastrointestinal malignancy: a large-scale, retrospective study. International Journal of Clinical Oncology. 28(7). 880–892. 2 indexed citations

15.

Guo, Ting, et al.. (2023). Induction of ferroptosis by artesunate nanoparticles is an effective therapeutic strategy for hepatocellular carcinoma. Cancer Nanotechnology. 14(1). 11 indexed citations

16.

Zhu, Yinxing, et al.. (2022). Platinum-based systematic therapy in triple-negative breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(1). 188678–188678. 54 indexed citations

17.

Guo, Ting, Yinxing Zhu, Miao Yue, et al.. (2022). The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer. Frontiers in Oncology. 12. 811783–811783. 10 indexed citations

18.

Zhu, Yinxing, et al.. (2022). Disitamab vedotin, a novel HER2-directed antibody–drug conjugate in gastric cancer and other solid tumors. Drugs of today. 58(10). 491–507. 7 indexed citations

19.

Zhu, Xuedan, Yinxing Zhu, Nan Chen, Cuiju Tang, & Junfeng Shi. (2022). The drugs screened by OncoVee^TM-Mini-PDX have significantly benefited the patient with HER2-positive advanced gastric cancer. Journal of Oncology Pharmacy Practice. 28(6). 1435–1440. 4 indexed citations

20.

Zhu, Yinxing, Xuedan Zhu, Xiaowei Wei, Cuiju Tang, & Wenwen Zhang. (2021). HER2-targeted therapies in gastric cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876(1). 188549–188549. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact